PSMF Lifecycle Management
The Pharmacovigilance System Master File (PSMF) is a document submitted to the European Medicines Agency (EMA) as part of the pharmacovigilance requirements for marketing authorization of a medicinal product in the European Union (EU). The PSMF provides a comprehensive overview of the company’s pharmacovigilance system and processes, including how adverse event (AE) reports are received, assessed, and processed.
We deliver QPPV & LPPV services leveraging our TOTALVigilance framework and our affiliates, staretgic partners across the globe a cost-effective, flexible, and scalable solution designed to enhance your regulatory complaince and real-time oversight. It combines qualified resources, knowledge, lean processes, and modern technology to deliver high-quality, compliant services. With adaptable service models and seamless integration into your existing systems and workflows, TOTALVigilance enhances operational efficiency, enables proactive oversight, and maximizes return on investment.
With over 15+ years experience, our medical writing team has helped several pharma and medical device companies by delivering clinical, non-clinical, regulatory, and post-marketing related medical writing services with the following principles:
- Ensuring accuracy and completeness of information
- Drafting content as per latest regulatory guidelines
- Effectively communicating complex information
- Applying latest methods in scientific research
- Leveraging latest technology for content creation
- Always meeting timelines and avoiding delays
QPPV & LPPV Services We Offer
At Techsol, our expert team of Medical writers have an extensive research background, scientific knowledge, and ample experience in contributing to clinical development programs for global pharma companies.
Following are the key focus areas where our medical writing team has the expertise to deliver high-quality services throughout the drug / device development lifecycle as per applicable regulatory guidelines:
PSMF Maintenance
The maintenance of the Pharmacovigilance System Master File (PSMF) is an ongoing process that involves regular review and updates to ensure its continued relevance and compliance with the regulatory requirements.
It is important to ensure that the PSMF is maintained regularly and effectively, as this helps to ensure the continued safety and well-being of patients who use the company’s products. The PSMF provides an overview of the company’s pharmacovigilance system and processes and is a critical component of the regulatory submission for marketing authorization of a medicinal product.
The following are the key steps involved in maintaining the PSMF:
Regular Review
The PSMF should be reviewed regularly, at least once a year, to ensure that it remains up-to-date and reflects any changes in the company's pharmacovigilance system.
Documentation of Changes
Any changes made to the PSMF should be documented and retained for future reference. This documentation should include the date of the change, the reason for the change, and the person responsible for the change.
Updating the PSMF
The PSMF should be updated to reflect any changes to the company's pharmacovigilance system, processes, and procedures. This may include updates to the company's policies, procedures, and training programs.
Regular Audits
Regular internal and external audits should be conducted to ensure the continued compliance of the pharmacovigilance system with the regulatory requirements. The results of these audits should be used to update the PSMF as necessary.
Supporting Documents
The PSMF should be supported by a range of other documents, including Standard Operating Procedures (SOPs), job descriptions, training materials, and forms. These supporting documents should also be regularly reviewed and updated as necessary.
TOTALVigilance Services
End-to-End Pharmacovigilance Solutions
Latest Relevant Case Studies
December 29, 2022
Establishing an Integrated Global Drug Safety and Signal Management Cloud Solution
December 29, 2022
Argus Safety Cloud Implementation and Validation on Oracle Cloud for HUGEL Pharma
December 29, 2022
Serious Adverse Event (SAE) Management, Review and Reporting to DCGI during the COVID 19 Pandemic for an Ophthalmology Clinical Study
Latest Relevant Insights
August 30, 2021
Literature Screening – Process overview, challenges en-route and the scope for automation
